Company News in the Life Science Industry

»

Reset 

Akari Announces First Quarter 2018 Financial Results and Update on its Growing Pipeline of Phase II and Phase III Clinical Trials

Read more ››
By: Nasdaq / GlobenewsWire - 17 Aug 2018
Related companies:  Akari Therapeutics Plc

Emergent BioSolutions to Participate in Series of Near-Term Investor Conferences

Read more ››
By: Nasdaq / GlobenewsWire - 17 Aug 2018
Related companies:  Emergent BioSolutions Inc.

Precipio Announces Second Quarter 2018 Financial Results and Provides Corporate Update

Read more ››
By: Nasdaq / GlobenewsWire - 17 Aug 2018
Related companies:  Precipio Diagnostics

Delcath Issues Letter to Stockholders

Read more ››
By: Nasdaq / GlobenewsWire - 17 Aug 2018
Related companies:  Delcath Systems Inc.

Evolus Granted Approval of DWP-450 by Health Canada

Read more ››
By: Nasdaq / GlobenewsWire - 17 Aug 2018
Related companies:  EVOLUS, INC.

Endocyte Announces Presentations at the American Chemical Society (ACS) National Meeting & Exposition

Read more ››
By: Nasdaq / GlobenewsWire - 17 Aug 2018
Related companies:  Endocyte, Inc.

VPR Brands, LP Announces Second Quarter 2018 Results

Read more ››
By: Nasdaq / GlobenewsWire - 17 Aug 2018

Navamedic ASA: Invitation to presentation of second quarter 2018

Read more ››
By: Nasdaq / GlobenewsWire - 17 Aug 2018
Related companies:  Navamedic AB | Navamedic ASA

Mateon Therapeutics Receives Notice of Partial Clinical Hold for OX1222 Study

Read more ››
By: Nasdaq / GlobenewsWire - 17 Aug 2018
Related companies:  MATEON THERAPEUTICS, INC.

American Pain Association President Selects Tree of Knowledge as CBD Supplier -- CFN Media

Read more ››
By: Nasdaq / GlobenewsWire - 17 Aug 2018

Golden Leaf Holdings Announces Acquisition of Combined Cultivation, Production and Retail License in California

Read more ››
By: Nasdaq / GlobenewsWire - 17 Aug 2018

BioStem Technologies, Inc. Completes 2016, 2017 Audit of Financial Statements

Read more ››
By: Nasdaq / GlobenewsWire - 17 Aug 2018
Related companies:  BioStem Technologies, Inc.

Syneos Health to Present at the 2018 Baird Global Healthcare Conference

Read more ››
By: Nasdaq / GlobenewsWire - 17 Aug 2018
Related companies:  Syneos Health, Inc

Cancer Immunotherapy Market to Reach Valuation of US$124.88 Bn by 2024, Says TMR

ALBANY, New York, August 17, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 17 Aug 2018
Related companies:  Transparency Market Research

FDA Approves EYLEA® (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration

TARRYTOWN, N.Y., Aug. 17, 2018 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for EYLEA(®) (aflibercept) Injection in patients with wet age-related... Read more ››

By: PR Newswire Association LLC. - 17 Aug 2018
Related companies:  Regeneron Pharmaceuticals, Inc.

ITUS Corporation to Present at Next Generation Dx Summit

SAN JOSE, Calif., Aug. 17, 2018 /PRNewswire/ -- ITUS Corporation (NASDAQ: ITUS) today announced that CEO, Dr. Amit Kumar, will be presenting at the Next Generation Dx Summit in Washington, D.C., being held on August 20(th)-24(th). Dr. Kumar's presentation, "Liquid Biopsy based on Flow... Read more ››

By: PR Newswire Association LLC. - 17 Aug 2018
Related companies:  ITUS Corporation

Healthy Interactions and Merck Announce Launch of Digital Health Platform Designed to Enhance Patient Engagement in Diabetes Management

KENILWORTH, N.J., Aug. 17, 2018 /PRNewswire/ -- Healthy Interactions, a global leader in health education, in collaboration with Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the launch of map4health(TM) - a digital platform and mobile application... Read more ››

By: PR Newswire Association LLC. - 17 Aug 2018
Related companies:  MERCK & CO., INC.

Eisai And Merck Announce FDA Approval Of LENVIMA® (lenvatinib) Capsules For First-Line Treatment Of Unresectable Hepatocellular Carcinoma (HCC)

WOODCLIFF LAKE, N.J. and KENILWORTH, N.J., Aug. 17, 2018 /PRNewswire/ -- Eisai Inc. and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) approved the kinase inhibitor LENVIMA(®) (lenvatinib) for the first-line... Read more ››

By: PR Newswire Association LLC. - 17 Aug 2018
Related companies:  MERCK & CO., INC.

Tolero Pharmaceuticals Announces Clinical Research Collaboration with AbbVie for Acute Myeloid Leukemia Trial

SALT LAKE CITY, Aug. 17, 2018 /PRNewswire/ -- Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologic and oncologic diseases, has entered into a clinical research collaboration with AbbVie, a research-based global biopharmaceutical... Read more ››

By: PR Newswire Association LLC. - 17 Aug 2018
Related companies:  TOLERO PHARMACEUTICALS, INC. | ABBVIE INC.

Smart Meter Announces AADE 2018 Poster Presentation on How iGlucose® System Impacts Remote Monitoring of Patients with Diabetes

TAMPA, Fla. and BALTIMORE, Aug. 17, 2018 /PRNewswire/ -- AADE Conference -- Smart Meter, an innovative diabetes management data, technology and solutions company, today announced a poster presentation, The Benefits of Remote... Read more ››

By: PR Newswire Association LLC. - 17 Aug 2018
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies